Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.
Tiana Tran, PharmD
Advertisement
Articles by Tiana Tran, PharmD
Daridorexant demonstrated significant reduction in daytime sleepiness among other measures.
Advertisement
Latest Updated Articles
FDA Approves Olipudase Alfa-rpcp for Acid Sphingomyelinase DeficiencyPublished: November 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
2
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
3
White House Announces Action to Increase Competition, Decrease Cost of Biosimilar Development
4
Pioglitazone Added to Metformin, Dapagliflozin Lowers Glucose for Patients With Diabetes
5
